Myelodysplastic syndrome - Latest research and news | Nature

Nature

Latest Research and Reviews

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT
- V. Potter
- L. Gras
- I. Yakoub-Agha
Research22 Nov 2023 Bone Marrow Transplantation
P: 1-8
Monitoring clone dynamics and reversibility in clonal haematopoiesis and myelodysplastic neoplasm associated with PARP inhibitor therapy—a role for early monitoring and intervention
- Ellen Nuttall Musson
- Rowan E. Miller
- Elspeth M. Payne
ResearchOpen Access17 Nov 2023 Leukemia
P: 1-4
Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis

A barcode-based approach applied to UK Biobank and an Icelandic cohort identifies drivers of clonal hematopoiesis (CH) and finds associations between CH and multiple diseases. Genome-wide association analyses identify 25 loci associated with CH susceptibility.
- Simon N. Stacey
- Florian Zink
- Kari Stefansson
ResearchOpen Access06 Nov 2023 Nature Genetics
Volume: 55, P: 2149-2159
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome
- Samia Harbi
- Louison Brac de la Perriere
- Raynier Devillier
Research03 Nov 2023 Bone Marrow Transplantation
P: 1-6
Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice
- Tiago L. Duarte
- Marta Lopes
- Delfim Duarte
Research19 Oct 2023 Leukemia
P: 1-13
Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia
- Maria Cancio
- Alexandre G. Troullioud Lucas
- Stephanie E. Smetsers
ResearchOpen Access17 Oct 2023 Bone Marrow Transplantation
P: 1-7

All Research & Reviews

News and Comment

Persistence of ex vivo expanded tumour and pathogen specific T-cells after allogeneic stem cell transplant for myeloid malignancies (the INTACT study)
- Wei Jiang
- Selmir Avdic
- Emily Blyth
Correspondence15 Sept 2023 Leukemia
Volume: 37, P: 2330-2333
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC
- Sandra Huber
- Constance Baer
- Gregor Hoermann
CorrespondenceOpen Access12 Aug 2023 Leukemia
Volume: 37, P: 2138-2141
What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias?
- Lin-Pierre Zhao
- Pierre Fenaux
Correspondence04 Aug 2023 Leukemia
Volume: 37, P: 1943
Skin lesions, arthritis, chondritis, and cytopenias
- Edwin U. Suárez
- Elena Prieto
- Luis Requena-Caballero
Correspondence04 Aug 2023 Leukemia
Volume: 37, P: 1941-1942
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable – a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
- Joanna Drozd-Sokolowska
- Luuk Gras
- Ibrahim Yakoub-Agha
Correspondence19 Nov 2022 Bone Marrow Transplantation
Volume: 58, P: 222-225
Should we give oligomonocytic chronic myelomonocytic leukemia a higher prominence in the next WHO Classification of Haematolymphoid Tumors?
- Xavier Calvo
Correspondence16 Nov 2022 Leukemia
Volume: 37, P: 250-251

All News & Comment

Search

Advanced search

Quick links